D
Exchange
—
Entity type
operating
Fiscal year end
Dec 30
Headquarters
DE
Recent Filings
- SC 13D/A85.9 KBDICE Therapeutics, Inc.Aug 9, 5:00 PM ET·0001104659-23-089350
- 8-K295.7 KBDICE Therapeutics, Inc.Aug 9, 9:26 AM ET·0001193125-23-206894
- 10-Q6.5 MBDICE Therapeutics, Inc.Aug 8, 4:01 PM ET·0000950170-23-039758
- SC 13G/A8.5 KBDICE Therapeutics, Inc.Jul 10, 10:20 AM ET·0000315066-23-002366
- SC 13D/A96.4 KBDICE Therapeutics, Inc.Jun 23, 5:10 PM ET·0001193125-23-173955
- SC 13D/A107.8 KBDICE Therapeutics, Inc.Jun 22, 4:32 PM ET·0001193125-23-172591
- SC 13D/A92.6 KBDICE Therapeutics, Inc.Jun 21, 5:00 PM ET·0001104659-23-073390
- 8-K957.3 KBDICE Therapeutics, Inc.Jun 20, 7:01 AM ET·0001193125-23-169553
- 8-K286.5 KBDICE Therapeutics, Inc.Jun 7, 4:26 PM ET·0000950170-23-026821
- 8-K317.4 KBDICE Therapeutics, Inc.May 11, 4:09 PM ET·0000950170-23-021228
Insiders
10Tickers
No tickers on record
Addresses
business
400 EAST JAMIE COURT SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
400 EAST JAMIE COURT SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- DiCE Molecules Holdings, LLC2021-09-10
- DiCE MOLECULES HOLDINGS, LLC2021-09-10